Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Dermatologic Therapy|December 13, 2019
Therapeutic potential of medicinal plants for the management of scabiesMuhammad Akram, Muhammad Riaz, Sarwat Noreen, et al.
Journal of Nanoscience and Nanotechnology|September 8, 2019
Synthesis of SPIONs-CNT Based Novel Nanocomposite for Effective Amperometric Sensing of First-Line Antituberculosis Drug RifampicinKhizra Bano, Sadia Zafar Bajwa, Ayesha Ihsan, et al.
Plant Physiology and Biochemistry : PPB|November 29, 2023
Calcium oxide nanoparticles mitigate lead stress in Abelmoschus esculentus though improving the key antioxidative enzymes, nutritional content and modulation of stress markersHafiz Zulqurnain Raza, Anis Ali Shah, Zahra Noreen, et al.
Cancer Gene Therapy|September 13, 2020
Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytesSadia Zafar, Dafne Carolina Alves Quixabeira, Tatiana Viktorovna Kudling, et al.
Blood Cancer Discovery|April 17, 2024
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell LymphomaLeo Meriranta, Selma Sorri, Kanutte Huse, et al.
International Journal of Pharmaceutics|April 22, 2018
Hollow mesoporous hydroxyapatite nanostructures; smart nanocarriers with high drug loading and controlled releasing featuresM Usman Munir, Ayesha Ihsan, Yasra Sarwar, et al.
Human Gene Therapy|October 14, 2020
Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient SamplesSadia Zafar, Saru Basnet, Inga-Maria Launonen, et al.
Oncoimmunology|September 14, 2020
Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibitionVictor Cervera-Carrascon, Dafne C A Quixabeira, Joao Manuel Santos, et al.
Frontiers in Immunology|August 9, 2021
Adenovirus Armed With TNFa and IL2 Added to aPD-1 Regimen Mediates Antitumor Efficacy in Tumors Refractory to aPD-1Victor Cervera-Carrascon, Dafne C A Quixabeira, Joao M Santos, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 24, 2024
Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokineSaru Basnet, Mirte Van der Heijden, Dafne C A Quixabeira, et al.
Pageof 8